The TRIBECA study: (TRI)fecta (B)ioprosthesis (E)valuation vs (C)arpentier Magna-Ease in (A)ortic position
Eur J Cardiothorac Surg. 2015 Mar 13
23
March
Mar
2015
11 years ago
Aim of this paper is to determine, on 791 patients underwent aortic valve replacement (469 Magna Ease, 322 Trifecta), whether the Trifecta bioprosthetic aortic valve produces postoperative haemodynamic results comparable with or better than those of the Magna Ease aortic valve bioprosthesis.
The haemodynamic performance of the Trifecta bioprosthesis was superior to that of the Magna Ease valve across all conventional prosthesis sizes, with almost no incidence of severe patient-prosthesis mismatch. The long-term follow-up is needed to determine whether these significant haemodynamic differences will persist, and influence clinical outcomes.
Go to full text
The haemodynamic performance of the Trifecta bioprosthesis was superior to that of the Magna Ease valve across all conventional prosthesis sizes, with almost no incidence of severe patient-prosthesis mismatch. The long-term follow-up is needed to determine whether these significant haemodynamic differences will persist, and influence clinical outcomes.
Go to full text